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Anenberg et al. (2010) estimated the global 
burden of respiratory mortality attributable to 
long-term ozone exposure based on a single 
observational study by Jerrett et al. (2009). 
Because no other study has clearly demon-
strated impacts of chronic ozone exposure 
on deaths from respiratory-related causes, we 
believe that reliance on the study by Jerrett 
et al.  to establish causality and global impact 
is misplaced and that the conclusions of 
Anenberg et al. are likely unfounded. 
Jerrett et al. (2009) carried out a follow-up 
analysis of the American Cancer Society 
(ACS) cohort. Other ACS studies reported 
no associa  tions between long-term ozone 
exposure and cardio  pulmonary mortality that 
are robust to model inclusion of co-pollutants   
(e.g., Krewski et al. 2000; Pope et al. 2002). 
In addition, other long-term studies of 
ozone-related respiratory or cardio  pulmonary 
mortality did not report positive associations 
(Goodman 2010; Health Effects Institute 
2009). Anenberg et al. (2010) suggested that 
long-term respiratory mortality is plausible 
because short-term ozone mortality has been 
documented, but inconsistent evidence for an 
association between short-term ozone expo-
sure and respiratory mortality indicates that 
this relationship is not well established. 
Jerrett et al. (2009) did not provide 
“clear” evidence of an association between 
long-term ozone exposure and respiratory 
mortality, as Anenberg et al. (2010) stated 
in their article. Jerrett et al. (2009) did not 
adequately control for potential confounding 
effects of particulate matter ≤ 2.5 µm in aero-
dynamic diameter (PM2.5) for several reasons. 
Jerrett et al. (2009) used only 2 years of data 
for PM2.5 (1999–2000) but ozone concen-
trations from 1977–2000. Although ozone 
and PM2.5 levels decreased considerably from 
1977 to 2000, they used higher ozone lev-
els observed in the past but only the more 
recent PM2.5 levels. Furthermore, their ozone 
metric focused on daily maximum hourly 
levels in the warm seasons, whereas they used 
annual average PM2.5 concentrations. As 
noted by Jerrett et al. (2009), this approach 
likely increased the potential to observe an 
association between ozone and mortality 
and decreased the ability to observe potential 
PM2.5 confounding of this association. In 
addition, confounding by other co-pollutants 
(e.g., sulfur dioxide), a clear issue in earlier 
ACS analyses (Krewski et al. 2000), was not 
examined. Accordingly, Jerrett et al. did not 
demon  strate an association between ozone 
and respiratory mortality that is independent 
of other co-pollutants. 
Another aspect of the Jerrett et al. (2009) 
study that is inconsistent with an association 
between long-term ambient ozone exposure 
and respiratory mortality is the biologically 
implausible, inverse associations of ozone 
with cardio  vascular and all-cause mortality. 
The magnitude of these associations is the 
same—although opposite in direction—as 
the risk estimate for respiratory mortal-
ity; thus, it is likely that associations of this 
magnitude are not indicative of a causal 
relationship. 
It was inappropriate for Jerrett et al. 
(2009) to combine data across cities for a 
U.S. national risk estimate, given the known 
geographic hetero  geneity of ozone-mortality 
findings (Goodman 2010). In addition, socio-
economic data (a potential confounder) was 
collected in 1982–1983 for the ACS study 
but never updated. For these reasons, the U.S. 
national risk estimate reported by Jerrett et al. 
(2009) should not be extrapolated globally. 
The analysis by Anenberg et al. (2010) 
was based on an uncorroborated study that 
likely mis  interpreted the findings regard-
ing ozone effects. The utility of estimating 
the global burden of an effect based on a 
single study, for which no causal association 
has been established in other studies, is not 
apparent. Conclusions drawn from such an 
analysis should be interpreted with caution. 
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Prueitt and Goodman raise concerns about 
our use of chronic ozone mortality relative 
risk (RR) estimates from Jerrett et al. (2009) 
to estimate the global burden of outdoor 
ozone and fine particulate matter (< 2.5 µm 
in aerodynamic diameter; PM2.5) on human 
mortality (Anenberg et al. 2010). We believe 
that our use of RR estimates from Jerrett 
et al. (2009) is justified and does not strongly 
affect our conclusions. Our goal of demon-
strating the use of chemical transport models 
in estimating the global burden of outdoor 
air pollution on mortality is not affected by 
the choice of risk estimates. Further, using 
chronic RR estimates for ozone has only 
a minor effect on our mortality estimates, 
because the mortalities attributed to PM2.5 
are much greater than those for ozone. 
We chose to use RR estimates from 
Jerrett et al. (2009) in our study (Anenberg 
et al. 2010) because they are consistent with 
the widely accepted RR estimates used for 
long-term PM2.5 mortality (Krewski et al. 
2009), as both are based on the American 
Cancer Society study cohort and capture 
delayed mortality effects (National Research 
Council 2008). 
In response to particular criticisms, we 
note that while Jerrett et al. (2009) found the 
first significant positive association between 
chronic ozone exposure and mortality in a 
major cohort study, some previous smaller 
cohort studies have also found positive asso-
ciations (National Research Council 2008). 
Biological plausibility for chronic ozone 
effects on respiratory mortality is evidenced by 
toxicology and human exposure studies that 
found that ozone affects airway inflammation, 
pulmonary function, and asthma induction 
and exacerbation (National Research Council 
2008). Using earlier PM2.5 data would be 
unlikely to affect confounding in the model, 
because using PM2.5 data from 1979–1983 
and 1999–2000 yields similar PM2.5 mortality 
associations (e.g., Krewski et al. 2009). Jerrett 
et al. (2009) also found that socio  economic 
data are not strong confounders and that 
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using more recent data is unlikely to change 
that conclusion (see Appendix of Jerrett et al. 
2009). Finally, national risk estimates are more 
applicable globally than city-specific estimates 
because they include larger and more diverse 
populations. 
However, because the evidence for 
chronic ozone mortality is more limited than 
the large body of evidence demonstrating 
mortality associations with short-term ozone 
exposure, we present here estimates of the 
global burden of ozone on mortality using 
RR estimates from Bell et al. (2004), a large 
multi  city study of short-term ozone mortal-
ity. We estimated mortalities daily using the 
difference between pre  industrial and present-
day 8-hr maximum ozone, and sum mortali-
ties over the 1-year simu  lation. We used the 
reported relationship for cardio  pulmonary 
mortality and daily average ozone [0.64% 
(95% posterior interval, 0.31–0.98%) for 
a 10-ppb increase], and corrected to 8-hr 
ozone using the reported ratio between daily 
8-hr and 24-hr average ozone associations 
with non  accidental mortality. 
Using these methods, we estimated 
362,000 (95% confidence interval, 173,000–
551,000) annual global pre  mature cardio-
pulmonary deaths attributable to ozone, 
approximately 50% of the 700,000 pre  mature 
deaths we calculated in our origi  nal study 
(Anenberg et al. 2010). Since estimated deaths 
due to PM2.5 (3.7 million) are an order of 
magnitude larger, using a short-term rather 
than long-term RR estimate for ozone has only 
a minor effect on the overall global burden of 
disease due to outdoor air pollution. As RRs 
for chronic ozone mortality are not as strongly 
supported as those for PM2.5, we expect that 
estimates of mortality burden will improve as 
research on chronic ozone exposure and mor-
tality continues globally.
S.C.A. and J.J.W. received unrestricted fund-
ing from the Merck Foundation to support a 
related project, and the Merck Foundation was 
unaware of this research. D.Q.T. is an employee 
of Science and Technology Corporation, working 
at NOAA facilities. L.W.H. declares he has no 
competing financial interests.
Susan C. Anenberg
J. Jason West
The University of North Carolina   
at Chapel Hill
Chapel Hill, North Carolina
E-mail: jasonwest@unc.edu
Larry W. Horowitz
NOAA Geophysical Fluid 
Dynamics Laboratory
Princeton, New Jersey
Daniel Q. Tong
Science and Technology Corporation at 
NOAA Air Resources Laboratory
Silver Spring, Maryland
RefeRences 
Anenberg SC, Horowitz LW, Tong DQ, West JJ. 2010. An esti-
mate of the global burden of anthropogenic ozone and 
fine particulate matter on premature human mortality 
using atmospheric modeling. Environ Health Perspect 
118:1189–1195. 
Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. 2004. 
Ozone and short-term mortality in 95 US urban communi-
ties, 1987-2000. JAMA 292:2372–2378.
Jerrett M, Burnett RT, Pope CA III, Ito K, Thurston G, Krewski D, 
et al. 2009. Long-term ozone exposure and mortality. 
N Engl J Med 360:1085–1095.
Krewski D, Jerrett M, Burnett RT, Ma R, Hughes E, Shi Y, 
et al. 2009. Extended Follow-up and Spatial Analysis of 
the American Cancer Society Study Linking Particulate 
Air Pollution and Mortality. Research Report 140. 
Boston:Health Effects Institute.
National Research Council, Committee on Estimating Mortality 
Risk Reduction Benefits from Decreasing Tropospheric 
Ozone Exposure. 2008. Estimating Mortality Risk Reduction 
and Economic Benefits from Controlling Ozone Air Pollution. 
Washington, DC:National Academies Press. Available: 
http://www.nap.edu/catalog.php?record_id=12198#toc 
[accessed 11 March 2011]. 
Influence of Selenium and 
Mercury on Age-Related Cataracts 
in the Brazilian Amazon
doi:10.1289/ehp.1003242
In their article, Lemire et al. (2010) provided 
important data on the frequency of age- 
related cataracts among adults in the Brazilian 
Amazon and found a correlation between age-
related cataracts and whole-blood total mer-
cury (Hg) concentrations and selenium (Se) 
levels in plasma and whole blood. However, 
in the “Discussion” of their paper, they stated 
that they “observed no adverse effects although 
Se concentrations were very high, reaching 
1,500 µg/L for [blood]-Se and 913 µg/L for 
[plasma]-Se” (Lemire et al. 2010). However, 
they did not mention the potential and sub-
stantial adverse health effects associated with 
a high body Se burden. There are potentially 
adverse consequences to Se body burden, 
such as hair loss (alopecia), tooth decay, nail 
changes, peripheral paresthesias, weakness, 
skin lesions, and diabetes (Hira et al. 2004; 
Nuttall 2006; Shearer 1975; Stranges et al. 
2010; Sutter et al. 2008; Yang et al. 1983). 
It would be valuable to know what Se-related 
adverse effects were observed by Lemire et al. 
(2010). Most studies, taken together, suggest 
a possible attenuation of Hg toxicity, probably 
as insoluble form of Hg selenide (Clarkson 
2002; International Programme on Chemical 
Safety 1990).
Selenium may be able to delay the onset 
of toxic effects in animal models exposed to 
methylmercury in the diet (Clarkson 2002; 
Ganther et al. 1972). However, the Hg–Se 
inter  action may not have an equivalent effect 
in some animals. There is evidence that 
coadministration of methylmercury and Se 
may lead to an important synergistic effect 
(Heinz and Hoffman 1998). In studies of 
persons who have been co-exposed to Hg 
and Se, toxic effects of Se should be taken 
into account to discover the potential syner-
gistic effect between Se and Hg. 
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We agree with the comments made by Minoia 
et al. in their letter. In this study population, 
we did evaluate the sentinel signs and symp- the sentinel signs and symp-
toms of selenosis (Lemire M, Philibert A, 
Fillion M, Passos CJS, Guimarães JRD, Correspondence
A 160  v o l u m e 119 | number 4 | April 2011  •  Environmental Health Perspectives
Barbosa F Jr, Mergler D, unpublished data), 
and we observed no association between any 
of the biomarkers of selenium (Se) status and 
signs and symptoms of selenosis (hair loss, 
broken nail walls, nail sloughing, skin lesions, 
garlic breath, gastro  intestinal dis  orders, and 
motor and sensory deficits), despite high Se 
body burdens. Other results in this study 
population show a positive association 
between Se status and motor performance 
(Lemire M, Fillion M, Frenette B, Passos CJS, 
Guimarães JRD, Barbosa F Jr, Mergler D, 
unpublished data). 
Guidelines on Se toxicity (International 
Programme on Chemical Safety 1986; U.S. 
Environmental Protection Agency 2002) 
are based mostly on reports of chronic sele-
nosis in a Chinese population with exces-
sive Se exposure, resulting from high Se in 
crops fertilized with coal ash highly rich in 
Se (Yang et al. 1983), and from combustion 
of Se-rich coal for domestic use (Liu et al. 
2007). Drinking water likewise contained 
unusually high concentrations of inorganic 
Se (Yang et al. 1983). Thus, several factors, 
such as exposure to toxic vapors from coal 
combustion and/or inorganic Se from drink-
ing water, may have contributed to toxic Se 
effects observed in China, primarily attrib-
uted to high organic Se in local crops. Recent 
studies reporting selenosis most often refer to 
excessive Se intake from nutritional supple-
ments or inorganic Se through drinking water 
(Sutter et al. 2008; Vinceti et al. 2010).
Our study (Lemire et al. 2010) was con- Lemire et al. 2010) was con- was con-
ducted in 2006, before the first publication 
on an association between Se supplemen-
tation and the incidence of self-reported 
type 2 diabetes (Stranges et al. 2007). In 
the  Amazonian population in our study, 
only 5 of the 448 partici  pants reported dia-
betes. Further studies should address the 
possible associations between high Se status 
and hyper  tension and hyper  cholesterolemia 
(reviewed by Stranges et al. 2010). 
Other evidence comes from Inuit, whose 
traditional diet of marine mammals is excep-
tionally rich in Se. The prevalence of dia-
betes in Nunavik, Québec, Canada, is low 
(3.5%). Ferland et al. (2009) observed no 
association between Se status and diabetes 
or plasma fasting glucose and insulin levels. 
Inverse association between blood Se and 
systolic blood pressure has also been reported 
(Valera et al. 2009). Hansen et al. (2004) 
pointed out that there are no recorded signs 
of selenosis in Greenland populations and 
that their high Se intake may be tolerated at 
higher levels. 
In Northern and Amazonian populations 
exposed to mercury (Hg), high dietary Se may 
offset Hg-mediated oxidative stress and/or   
be required to maintain optimal seleno-
enzymes. There may be consequently less 
“excess” Se and little or no Se toxicity (Khan 
and Wang 2009). 
Whether dietary Se is less toxic in Hg- 
exposed populations remains unanswered. 
However, even if there is increasing evidence 
that Se can offset some toxic effects of Hg, 
it may be inefficient against all Hg-mediated 
effects. Preventive actions should continue to 
focus on reducing Hg exposure rather than 
increasing Se status.
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Erratum
The February 2011 article “Avoiding 
Health  Pitfalls  of  Home  Energy-
Efficiency Retrofits” [Environ Health 
Perspect 119:A76–A79 (2011)] incor-
rectly listed 1,2,3-trichloropropane 
(TCP) as a flame retardant used in spray 
polyurethane foams. The correct com-
pound should have been tris(1-chloro-
2-propyl) phosphate (TCPP). 
EHP regrets the error.
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